AM - Technology Transfer

Jubilant Pharma Limited is a global integrated pharmaceutical company that offers a diverse range of products and services to customers worldwide. The business is organized into two segments: Specialty Pharmaceuticals, which includes Radiopharmaceuticals (including Radio pharmacies), Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products, and Generics & APIs, comprising Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma, with Research & Development units in Noida and Mysore, India. JGL operates two manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, specializing in APIs and Dosage manufacturing, respectively. The Mysore manufacturing site, spread over 69 acres, is USFDA approved and focuses on manufacturing APIs for Lifestyle-driven Therapeutic Areas (CVS, CNS). It holds a leading market position in four APIs and is among the top three players for three other APIs. The Roorkee facility is a state-of-the-art site approved by multiple regulatory bodies like USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA, catering to EU, Canada, and emerging markets following a B2B model. Both manufacturing units are supported by approximately 500 research and development professionals based in Noida and Mysore. The R&D team focuses on developing new products, including APIs, Solid Dosage Formulations of Oral Solid, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. Additionally, in-house BA/BE studies are conducted at an 80-bed facility with global regulatory accreditations. JGL's Regulatory Affairs & IPR professionals ensure a unique portfolio of patents and product filings in both regulatory and non-regulatory markets. The revenue of Jubilant Pharma has been consistently growing, reaching INR 53,240 Million during the Financial Year 2018-19 compared to INR 39,950 Million in 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,